These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 39181089)
1. Histological evaluation of renal progenitor/stem cells, renal mesenchymal stem-like cells, and endothelial progenitor cells in chronic kidney disease and end-stage renal disease, and molecular docking analysis of drug-receptor interactions. Afshar A; Khoradmehr A; Zare A; Basouli N; Keshtkar M; Nabipour I; Mahdipour M; Mahmoudpour M; Kaliyev AA; Mussin NM; Baspakova A; Tamadon A Tissue Cell; 2024 Oct; 90():102527. PubMed ID: 39181089 [TBL] [Abstract][Full Text] [Related]
2. Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease. Chen YT; Cheng BC; Ko SF; Chen CH; Tsai TH; Leu S; Chang HW; Chung SY; Chua S; Yeh KH; Chen YL; Yip HK Clin Exp Nephrol; 2013 Feb; 17(1):83-91. PubMed ID: 22814956 [TBL] [Abstract][Full Text] [Related]
3. Endothelial Progenitor Cells at the Interface of Chronic Kidney Disease: From Biology to Therapeutic Advancement. Coppolino G; Cernaro V; Placida G; Leonardi G; Basile G; Bolignano D Curr Med Chem; 2018; 25(35):4545-4551. PubMed ID: 28933292 [TBL] [Abstract][Full Text] [Related]
4. Stem cells in kidney diseases. Soler MJ; José Tomas OP J Stem Cells; 2012; 7(4):245-59. PubMed ID: 24196799 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease. Ribeiro PC; Lojudice FH; Fernandes-Charpiot IMM; Baptista MASF; de Almeida Araújo S; Mendes GEF; Sogayar MC; Abbud-Filho M; Caldas HC Stem Cell Res Ther; 2020 Dec; 11(1):530. PubMed ID: 33298161 [TBL] [Abstract][Full Text] [Related]
6. Progenitor-like cells derived from mouse kidney protect against renal fibrosis in a remnant kidney model via decreased endothelial mesenchymal transition. Chen CL; Chou KJ; Fang HC; Hsu CY; Huang WC; Huang CW; Huang CK; Chen HY; Lee PT Stem Cell Res Ther; 2015 Dec; 6():239. PubMed ID: 26631265 [TBL] [Abstract][Full Text] [Related]
7. Improved differentiation of human enriched CD133+CD24 Ehsani E; Shekarchian S; Baharvand H; Aghdami N; Moghadasali R Differentiation; 2019; 109():1-8. PubMed ID: 31323479 [TBL] [Abstract][Full Text] [Related]
8. Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Jie KE; Zaikova MA; Bergevoet MW; Westerweel PE; Rastmanesh M; Blankestijn PJ; Boer WH; Braam B; Verhaar MC Nephrol Dial Transplant; 2010 Jun; 25(6):1875-82. PubMed ID: 20083473 [TBL] [Abstract][Full Text] [Related]
9. Endothelial damage and vascular calcification in patients with chronic kidney disease. Soriano S; Carmona A; Triviño F; Rodriguez M; Alvarez-Benito M; Martín-Malo A; Alvarez-Lara MA; Ramírez R; Aljama P; Carracedo J Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1302-11. PubMed ID: 25339701 [TBL] [Abstract][Full Text] [Related]
10. Rejuvenated endothelial progenitor cells through overexpression of cellular prion protein effectively salvaged the critical limb ischemia in rats with preexisting chronic kidney disease. Yeh JP; Sung PH; Chiang JY; Huang CR; Chen YL; Lai JP; Sheu JJ Stem Cell Res Ther; 2022 Sep; 13(1):447. PubMed ID: 36056416 [TBL] [Abstract][Full Text] [Related]
11. The therapeutic potential of Camel Wharton jelly mesenchymal stem cells (CWJ-MSCs) in canine chronic kidney disease model. El Miniawy HMF; Farghali HA; Khattab MS; Emam IA; Ibrahem EM; Sabry D; Ismail TA Stem Cell Res Ther; 2022 Jul; 13(1):387. PubMed ID: 35908006 [TBL] [Abstract][Full Text] [Related]
12. Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition. Sung PH; Chen KH; Li YC; Chiang JY; Lee MS; Yip HK Biomed Pharmacother; 2019 Mar; 111():1088-1102. PubMed ID: 30841422 [TBL] [Abstract][Full Text] [Related]
13. Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial. Awal HB; Nandula SR; Domingues CC; Dore FJ; Kundu N; Brichacek B; Fakhri M; Elzarki A; Ahmadi N; Safai S; Fosso M; Amdur RL; Sen S Cardiovasc Diabetol; 2020 Jun; 19(1):72. PubMed ID: 32493344 [TBL] [Abstract][Full Text] [Related]
14. Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure. Tan HL; Yap JQ; Qian Q Blood Purif; 2016; 41(1-3):144-50. PubMed ID: 26764483 [TBL] [Abstract][Full Text] [Related]
15. Changes in sensory proteins in the bladder urothelium of patients with chronic kidney disease and end-stage renal disease. Chen SF; Lee CL; Kuo HC Low Urin Tract Symptoms; 2019 Apr; 11(2):O202-O208. PubMed ID: 30198096 [TBL] [Abstract][Full Text] [Related]
16. Renal Injury Repair: How About the Role of Stem Cells. Li JS; Li B Adv Exp Med Biol; 2019; 1165():661-670. PubMed ID: 31399989 [TBL] [Abstract][Full Text] [Related]
17. Circulating Endothelial Progenitor Cell Levels Predict Cardiovascular Events in End-Stage Renal Disease Patients on Maintenance Hemodialysis. Lee HJ; Kim W; Kim WS; Woo JS; Kim YG; Moon JY; Lee SH; Ihm CG; Lee TW; Jeong KH Nephron; 2015; 130(3):151-8. PubMed ID: 26089157 [TBL] [Abstract][Full Text] [Related]
18. Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease. Rimes-Stigare C; Frumento P; Bottai M; Mårtensson J; Martling CR; Bell M Crit Care; 2015 Nov; 19():383. PubMed ID: 26526622 [TBL] [Abstract][Full Text] [Related]
19. Reno-protection of Urine-derived Stem Cells in A Chronic Kidney Disease Rat Model Induced by Renal Ischemia and Nephrotoxicity. Zhang C; George SK; Wu R; Thakker PU; Abolbashari M; Kim TH; Ko IK; Zhang Y; Sun Y; Jackson J; Lee SJ; Yoo JJ; Atala A Int J Biol Sci; 2020; 16(3):435-446. PubMed ID: 32015680 [No Abstract] [Full Text] [Related]
20. Dysfunctional high-density lipoproteins in children with chronic kidney disease. Kaseda R; Jabs K; Hunley TE; Jones D; Bian A; Allen RM; Vickers KC; Yancey PG; Linton MF; Fazio S; Kon V Metabolism; 2015 Feb; 64(2):263-73. PubMed ID: 25467845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]